Key Highlights

  • 7.41% is the move in iRhythm Holdings, Inc. (NASDAQ:IRTC) in the November 18, 2026 session, to a traded price of USD 98.31 from a calculated prior close of USD 91.53, a calculated gain of USD 6.78 per share.
  • 221.6 million is the USD Revenue iRhythm Holdings, Inc. (NASDAQ:IRTC) reported for the third quarter of 2026, up 14.9% from USD 192.9 million, with gross Margin of 74.2%, up 310 basis points year over year.
  • 29.9 million is the USD GAAP net loss for the quarter, or USD 0.90 per share, after USD 49.8 million of litigation settlements, against a USD 5.2 million loss, or USD 0.16 per share, a year earlier.
  • 560.7 million is the USD unrestricted cash, cash equivalents and marketable securities at September 30, 2026, alongside 2026 revenue guidance of USD 890 million to USD 895 million and adjusted EBITDA of USD 51.2 million in the quarter.

What Moved iRhythm Holdings, Inc. (NASDAQ:IRTC) in Trading on November 18, 2026 (+USD 6.78, +7.41%)

The traded price of iRhythm Holdings, Inc. (NASDAQ:IRTC) in today's session on November 18, 2026 is USD 98.31, a move of +7.41% on Volume of 287.59K shares. On a calculated basis, the prior close from November 17, 2026 was USD 91.53 (USD 98.31 divided by 1.0741) and the USD move is +USD 6.78 (price minus prior close). The stock opened 1.50% above the prior close, a calculated opening price of about USD 92.90, and traded 5.82% above the open. Calculated dollar volume was about USD 28.27 million. With 33,185 thousand shares outstanding at September 30, 2026, the calculated market Capitalization is about USD 3.26 billion.

The Rationale: No Same-Day Catalyst, Third Quarter Results for iRhythm Holdings, Inc. (NASDAQ:IRTC)

No specific catalyst for the November 18, 2026 move was identified in published coverage. The most recent reported period is the third quarter of 2026, ended September 30, 2026, announced on November 5, 2026. Revenue was USD 221.6 million, up 14.9% from USD 192.9 million. Adjusted EBITDA was USD 51.2 million, a 23.1% margin, compared with USD 21.6 million a year earlier. GAAP net loss was USD 29.9 million, driven by litigation settlements of USD 49.8 million in the quarter and USD 63.7 million for nine months, relating to Baxter Patent litigation and a securities class action.

Valuation, Liquidity and Risks for iRhythm Holdings, Inc. (NASDAQ:IRTC)

Unrestricted cash, cash equivalents and marketable securities were USD 560.7 million at September 30, 2026. The nine-month GAAP net loss was USD 44.2 million, or USD 1.35 per share. Guidance for 2026 is revenue of USD 890 million to USD 895 million, including about USD 16 million from VitalConnect, and an adjusted EBITDA margin of 15.5% to 16.0%. The calculated market capitalization of about USD 3.26 billion is 3.7 times 2026 revenue at the guidance midpoint of USD 892.5 million (calculated). Risks include litigation costs.

Where Things Stand

iRhythm Holdings, Inc. (NASDAQ:IRTC) traded at USD 98.31 in today's session on November 18, 2026, up +7.41% from a calculated prior close of USD 91.53, on volume of 287.59K shares. No specific catalyst for the move was identified in published coverage. The latest reported quarter, ended September 30, 2026, showed revenue of USD 221.6 million, up 14.9%, adjusted EBITDA of USD 51.2 million, a GAAP net loss of USD 29.9 million after litigation settlements, and cash of USD 560.7 million. Guidance for 2026 revenue is USD 890 million to USD 895 million. This article is informational and is not Investment advice.